Saint Bella — Investor Fact Book
Saint Bella Group 圣贝拉
FY2025 results (announced 2026-03-30) + filings through mid-2026 · generated 2026-08-15
Filed and verified facts only. Safe to share. Numbers trace to the company’s HKEX filings.
RMB 1,045.9M
FY2025 revenue
+31.0% YoY
RMB 124.6M
Adjusted net profit
+194.9% · margin 11.9%
36.0%
Gross margin
+2.1pp (was 33.9%)
140 + 8
Centers
mainland + overseas · 41 cities
No.1
Market rank
Asia & China, 2024 · 1.2% share
RMB 267k
Flagship ASP
Saint Bella brand · +11.6%, 8 yrs up
100,000+
Families served
over 8 years
RMB 549.6M
Cash position
up from 66.0M (2024)
FiledFrom HKEX filings (prospectus, results, announcements) — the primary record.
AnalystFrom a third-party analyst report; ranks below the company's own filings.
PressFrom the company website or press coverage.
Financials
P&L, four-year track, segments, margins
FY2025 revenue
RMB 1,045.859M, +31.0% (FY2024: 798.666M)
FY2025 gross profit & margin
GP RMB 376.226M (+39.1%); gross margin 36.0% (was 33.9%)
FY2025 statutory net profit
RMB 411.180M — includes a one-off, non-cash +318.189M fair-value gain (preferred shares converting at IPO). Durable operating figure = adjusted NP 124.6M (F-107).
FY2025 adjusted net profit & margin
RMB 124.601M, +194.9% (FY2024: 42.256M); margin 11.9% (was 5.3%)
FY2025 adjusted EBITDA
RMB 174.346M (FY2024: 72.474M)
FY2025 EPS
Basic RMB 1.27; diluted RMB 0.27 (FY2024: LPS 102.12)
Four-year revenue track
2022: 471.5M → 2023: 559.9M → 2024: 798.7M → 2025: 1,045.9M (2023→2025 CAGR 36.7%)
Segment — postpartum centers
RMB 899.3M, +30.8% (~86% of revenue)
Segment — home care (PrimeCare)
RMB 81.9M, +36.7%; gross margin 37.2%
Segment — health food (GHT)
RMB 64.7M, +26.3%; gross margin 72.8% (+11.3pp); No.1 Tmall nutrition 2022–25
Revenue by geography
Mainland RMB 1,021.6M; overseas 24.3M (~2.3%); services 968.5M / products 77.3M
Expense ratios (adjusted)
Marketing 10.5% (−1.4pp); admin 14.6% (−1.4pp)
Cash position
Cash RMB 549.6M (2024: 66.0M) + restricted/deposits 158.3M
Dividend
None paid or declared for FY2025
Balance-sheet turnaround
Total equity +998.6M end-2025 (owners +983.9M) vs attributable −1,460.4M end-2024 — pre-IPO preferred-share liabilities cleared at listing
H1 2025 results
Revenue 449.5M (+25.6%); GM 37.6%; adjusted NP 38.8M (+126.1%), margin 8.6%; combined revenue incl. managed 522.5M
Gross margin by segment 2022/23/24
Total 29.9/36.5/33.9%; centers 28.7/34.1/31.8%; food 43.7/63.3/61.5%
Operating cash flow
Positive every year: +24.1 / +56.7 / +49.1M (2022/23/24) — cash-generative even through the statutory-loss years
Unit economics
ASP, pricing, conversion, payback
ASP by brand FY2025
Group RMB 156,059 (+5.0%); Saint Bella 266,796 (+11.6%); Baby Bella 108,375 (+12.6%); Bella Isla 171,896 (+2.8%)
Flagship pricing power (chairman)
Saint Bella brand ASP RMB 267,000, +11.6%; double-digit ASP growth 8 consecutive years; never cut prices
Pricing 2024 (prospectus)
Avg revenue/customer: Saint Bella 239,155; Bella Isla 167,197; Baby Bella 96,246; per room-night RMB 7,015; 28-day packages from 138,800 / 108,800 / 68,800
Secondary-sales conversion & diversified mix
95.5% comprehensive secondary-sales conversion; diversified offerings 29.5% of revenue
Hotel asset-light model
Centers inside upscale hotels; 405/459/867 rooms reserved 2022/23/24; new centers cash-flow positive within ~3 months; minimal renovation capex
Center revenue by brand 2024
Saint Bella care 269.6M + recovery 54.8M; Baby Bella care 222.4M + recovery 32.4M; Bella Isla 43.9M + 5.4M
Home care metrics
~9,500 licensed baby-sitters (+36.0%); avg contract 122.8 days; 823 customers (+20.9%); renewal ~56.7%
Staffing & volumes (prospectus)
693 qualified nursing specialists; 4,439 postpartum packages sold 2024 (~38% via referrals/own channels)
Network & expansion
Store counts, overseas, M&A
Mainland center count
140 mainland centers as of 2025-12-31 (net +63 from 77)
Global network scale
140 stores across 41 cities worldwide; No.1 in postpartum care in Asia by scale; outlook 'nearly 150 stores'
Center network by year
2022: 36 → 2023: 43 → 2024: 77 → Jun 2025: 96 (62 self-op / 34 managed)
Footprint + 2026 plan
140 stores / 41 cities at AR date; 2026 plan: 15 new stores in 10 cities; countries: China (incl. HK), Singapore, US, Thailand
Footprint at prospectus
27 mainland cities + HK + Singapore + Greater LA; ~30 cities, 3 countries
Overseas footprint FY2025
4 overseas cities, 8 overseas centers in 2025; overseas GMV +280.0% YoY (off a ~2.3%-of-revenue base); markets: Singapore, North America, Australia
Five-city expansion (signed)
Eastern US, UK, France, Thailand, Australia; strategic agreements SIGNED with partners in NY, London, Paris, Bangkok
Wuhan Freya acquisition
30–40% minority stakes in 4 Wuhan Freya (弗蕾亚) companies for ~RMB 22.4M; board control of 3 (consolidated); option to 60–80%. Freya: est. 2013, 3 shops, 160+ rooms, ASP ~RMB 50k, ~10,000 HNW families
US debut
Jul 15 2025: Waldorf Astoria Monarch Beach (CA) + Baccarat Hotel New York
FY2026 outlook
Organic + M&A; 'only postpartum brand globally with total scale >RMB 1B'; overseas into Europe + Middle East; Dr. Bella across nearly 150 stores; no quantitative guidance
Brands & lifecycle
Portfolio, tiers, the membership pillar
Brand portfolio & launch years
Saint Bella 2017; Baby Bella 2019; Bella Isla 2024; STB (recovery) 2022; PrimeCare 予家 2018; GHT 广禾堂 acquired Oct 2021; S-bra acquired May 2022
Existing membership program
圣贝拉会员权益中心 with tiers 悦己 (Self-care) / 金卡 (Gold) / 铂金 (Platinum): concierge benefits, members-only events, points mall, UCCA art visits + Kids study tours, psychology counseling, IPHI infant sleep guidance, 24H 1-on-1 in-home nurse
GHT 广禾堂 category position
No.1 in Tmall postpartum-nutrition category 2022–2025; food gross margin 72.8%; ~70% e-commerce share (founded 2003 Shanghai)
Average customer spend
>RMB 230k avg spend (2024); nightly ~6,740–7,015 — above every benchmark's annual membership fee
Awards
2023 Robb Report Best of the Best (Luxury Family Wellness); Marie Claire Top 100; Forbes China maternal & child health Top 10
Market & share
TAM, penetration, competitive rank
Market position (F&S)
Largest postpartum care+recovery group in Asia AND China by 2024 center revenue (RMB 628M, 1.2% share; No.2 = 418M); fastest-growing scaled group (26.4% CAGR); No.1 ultra-premium (374M vs 89M)
Competitive ranking (F&S)
No.1 by 2024 center revenue: Group 628M (1.2%) vs A 418M (0.8%), E-Korea 403M, B 366M, F 279M
Market size (F&S)
Postpartum care+recovery: RMB 38.6B (2019) → 67.5B (2024), CAGR 11.8%; → 79.3B (2025E) → 200.8B (2030E), CAGR 20.4%
Penetration & headroom (F&S)
Postpartum care services 7.5% (2019) → 17.0% (2024); centers 1.3% → 6.0%; South Korea / Taiwan >60%
Market context (FY2025 results)
China home care industry RMB 805.3B (2025E) → >928.0B (2026E); postpartum+childcare+nutrition 298.4B in 2025 (+17.5%)
Adjacent markets (F&S)
Family care industry 711.3B (2024) → 1,443.8B (2030E); home childcare 35.8B → 105.2B (2030E); China births 14.7M (2019) → 9.5M (2024)
Natal-policy tailwind
National childcare subsidy RMB 3,600/child/yr for under-3s (from 2025-01-01; >24M recipients); under-3 tax deduction raised to RMB 2,000/mo
AI & technology
Dr. Bella, Yunji, robotics fund
AI business 2025 (filed)
Launched Dr. Bella (self-developed vertical AI agent); strategic investment in WITH1000 (>10M sets clinical data from 400+ institutions); Yunji partnership; embodied-intelligence fund
Yunji robotics framework
NON-BINDING cooperation framework with Beijing Yunji Technology (02670.HK): AI + robotics in home care; link ~150 scenarios + >1M clinical data sets; JV 'to be explored'; 'may or may not proceed'
Robotics fund
Investor in a RMB 1B fund (Shanghai Dunhong Capital, >10B AUM; prior: Unitree, Lingban), targeting embodied robots; funded from operating income
Dr. Bella product
Dr. Bella = AI health agent for women across pregnancy, birth and parenting
Ownership & governance
Shareholders, cornerstones, buyback
Listing
Dealings commenced 2025-06-26, HKEX Main Board, stock code 2508
Global offering
95,420,000 offer shares at HK$6.58 fixed price; board lot 500
Final offer outcome
Offer Size Adjustment Option fully exercised: 109,733,000 shares at HK$6.58; net proceeds HK$629.95M; HK tranche 193.00x, intl 15.59x subscribed
Market cap at offer price
HK$3,917.9M
Use of proceeds
~29% network expansion; ~37% new services/products (incl. elderly care, retail, recovery); ~6% training; ~18% R&D/AI/data; ~9% working capital
Substantial shareholders post-IPO
Danny Xiang 35.68%; Minee Lin 9.98%; Tencent Mobility 9.75%
Pre-IPO investor register
Tencent 11.61% (RMB 150M Series C), Gaorong 8.26%, Ningbo Tangzhu 6.61%, SHK 2.98%, China Life 1.96%, Mirae 1.75%, C Capital (Adrian Cheng) 1.69%, Swire 0.68%; total pre-IPO raised >RMB 300M
Cornerstone investors
US$41.46M / 49.443M shares (51.82% of base): GIMM $6.37M, ChinaAMC(HK) $4.0M, JKKB $13.08M, Carl Wu $1.0M, SS Morgan $6.0M, Minwise $4.0M, Wang Qianqing $7.0M
Ownership & strategic holders
Danny Xiang + vehicles ~35.7% controlling; strategic holders incl. Tencent, Swire Properties, SHK Strategic, Mirae Asset
Founder
Danny Xiang (向华), 38 — founder / Chairman / CEO; Oxford engineering; ex-UBS Asia M&A
Co-founder
Minee Lin (林宛颐), 37 — co-founder & COO since Jul 2017
Board & INEDs
Liang Jun (Tencent, non-exec); INEDs Wu Shuqing, Rainer Bürkle (ex-Marriott Greater China luxury VP), Shen Guanxian (ex-GS/Citi/CICC)
L Catterton cooperation
Strategic cooperation announced via HKEX voluntary announcement (2026-03-18): technology & consumer-insight support, joint investment incubation + acquisitions toward a multi-brand global home-care group
L Catterton scope
L Catterton (~$40B AUM, 300+ brands): international expansion, HNW consumer insights, membership-system optimization, M&A pipeline
Share buyback
Up to HK$100M on-market buyback, price cap HK$6.85, 2026-06-30 → 2028-06-29; rationale: price below intrinsic value
Share price vs IPO
IPO HK$6.58 (Jun 2025); ~HK$5.45 (Feb 2026); ~HK$3.39 (Jul 2026) ≈ −48% vs IPO; award trustee bought at avg HK$3.81
IPO proceeds deployment
Net HK$709.1M raised (incl. over-allotment); only HK$113.1M (~16%) deployed in 2025 — dry powder for expansion + M&A
Insider buying & lock-up
Controlling shareholder increased his stake with a voluntary lock-up (2026-01-09); 2025 incentive plan authorises repurchase up to 2% of shares via Futu Trust
Company rename
SAINT BELLA Inc. → SAINT BELLA GROUP LIMITED (聖貝拉集團有限公司); EGM 2026-02-05
Membership benchmarks
RH, Soho House, Quintessentially, Amex
Restoration Hardware (RH) membership
Members drove ~98% of core sales; ~265,000 members (FY2024); fee income immaterial vs ~$3.2B revenue
RH fee model
Grey Card $100 → $200/yr; member discount 25% → 30%; converts discounting into a paid club, self-selects high-intent customers
Amex Centurion
Invite-only; $10,000 initiation + $5,000/yr; pure status-gate pricing
Quintessentially
Tiers ~£2,000 (entry) → £25,000+ (Elite); travel / access / education advisory — closest HNW family-concierge model
Soho House
£3,800/yr Every House; 270k+ members, 48 houses; taken private $2.7B EV (Aug 2025), never profitable as a listed co.
Risk factors
Key risk factors from the prospectus
Top prospectus risk factors
Competition; growth-execution; service quality; negative publicity; marketing efficiency; dependence on hotel relationships (generally no long-term agreements); new/acquired centers underperforming; incidents/liability; regulatory compliance
Full fact registry
Filed and verified facts only. Search filters this table too; the chips filter by source.
| ID | Claim | Value | As-of | Source | Section |
|---|---|---|---|---|---|
| F-063 | Dr. Bella product | Dr. Bella = AI health agent for women across pregnancy, birth and parenting | 2026-07-22 | Press | ai-tech |
| F-346 | AI business 2025 (filed) | Launched Dr. Bella (self-developed vertical AI agent); strategic investment in WITH1000 (>10M sets clinical data from 400+ institutions); Yunji partnership; embodied-intelligence fund | FY2025 | Filed | ai-tech |
| F-347 | Yunji robotics framework | NON-BINDING cooperation framework with Beijing Yunji Technology (02670.HK): AI + robotics in home care; link ~150 scenarios + >1M clinical data sets; JV 'to be explored'; 'may or may not proceed' | 2026-01-19 | Filed | ai-tech |
| F-348 | Robotics fund | Investor in a RMB 1B fund (Shanghai Dunhong Capital, >10B AUM; prior: Unitree, Lingban), targeting embodied robots; funded from operating income | 2026-03-24 | Filed | ai-tech |
| F-391 | Restoration Hardware (RH) membership | Members drove ~98% of core sales; ~265,000 members (FY2024); fee income immaterial vs ~$3.2B revenue | 2025-02-01 | Press | benchmarks |
| F-392 | RH fee model | Grey Card $100 → $200/yr; member discount 25% → 30%; converts discounting into a paid club, self-selects high-intent customers | 2025-06-11 | Press | benchmarks |
| F-393 | Amex Centurion | Invite-only; $10,000 initiation + $5,000/yr; pure status-gate pricing | 2026 | Press | benchmarks |
| F-394 | Quintessentially | Tiers ~£2,000 (entry) → £25,000+ (Elite); travel / access / education advisory — closest HNW family-concierge model | 2026 | Press | benchmarks |
| F-395 | Soho House | £3,800/yr Every House; 270k+ members, 48 houses; taken private $2.7B EV (Aug 2025), never profitable as a listed co. | 2025-08-18 | Press | benchmarks |
| F-058 | Brand portfolio & launch years | Saint Bella 2017; Baby Bella 2019; Bella Isla 2024; STB (recovery) 2022; PrimeCare 予家 2018; GHT 广禾堂 acquired Oct 2021; S-bra acquired May 2022 | 2025-06-18 | Filed | brands |
| F-060 | Existing membership program | 圣贝拉会员权益中心 with tiers 悦己 (Self-care) / 金卡 (Gold) / 铂金 (Platinum): concierge benefits, members-only events, points mall, UCCA art visits + Kids study tours, psychology counseling, IPHI infant sleep guidance, 24H 1-on-1 in-home nurse | 2026-07-22 | Press | brands |
| F-061 | Awards | 2023 Robb Report Best of the Best (Luxury Family Wellness); Marie Claire Top 100; Forbes China maternal & child health Top 10 | 2023 | Press | brands |
| F-112 | GHT 广禾堂 category position | No.1 in Tmall postpartum-nutrition category 2022–2025; food gross margin 72.8%; ~70% e-commerce share (founded 2003 Shanghai) | FY2025 | Filed | brands |
| F-234 | Average customer spend | >RMB 230k avg spend (2024); nightly ~6,740–7,015 — above every benchmark's annual membership fee | 2024 | Press | brands |
| F-104 | FY2025 revenue | RMB 1,045.859M, +31.0% (FY2024: 798.666M) | FY2025 | Filed | financials |
| F-105 | FY2025 gross profit & margin | GP RMB 376.226M (+39.1%); gross margin 36.0% (was 33.9%) | FY2025 | Filed | financials |
| F-106 | FY2025 statutory net profit | RMB 411.180M — includes a one-off, non-cash +318.189M fair-value gain (preferred shares converting at IPO). Durable operating figure = adjusted NP 124.6M (F-107). | FY2025 | Filed | financials |
| F-107 | FY2025 adjusted net profit & margin | RMB 124.601M, +194.9% (FY2024: 42.256M); margin 11.9% (was 5.3%) | FY2025 | Filed | financials |
| F-108 | FY2025 adjusted EBITDA | RMB 174.346M (FY2024: 72.474M) | FY2025 | Filed | financials |
| F-109 | FY2025 EPS | Basic RMB 1.27; diluted RMB 0.27 (FY2024: LPS 102.12) | FY2025 | Filed | financials |
| F-110 | Segment — postpartum centers | RMB 899.3M, +30.8% (~86% of revenue) | FY2025 | Filed | financials |
| F-111 | Segment — home care (PrimeCare) | RMB 81.9M, +36.7%; gross margin 37.2% | FY2025 | Filed | financials |
| F-112 | Segment — health food (GHT) | RMB 64.7M, +26.3%; gross margin 72.8% (+11.3pp); No.1 Tmall nutrition 2022–25 | FY2025 | Filed | financials |
| F-113 | Revenue by geography | Mainland RMB 1,021.6M; overseas 24.3M (~2.3%); services 968.5M / products 77.3M | FY2025 | Filed | financials |
| F-114 | Expense ratios (adjusted) | Marketing 10.5% (−1.4pp); admin 14.6% (−1.4pp) | FY2025 | Filed | financials |
| F-115 | Dividend | None paid or declared for FY2025 | FY2025 | Filed | financials |
| F-116 | Cash position | Cash RMB 549.6M (2024: 66.0M) + restricted/deposits 158.3M | 2025-12-31 | Filed | financials |
| F-118 | Four-year revenue track | 2022: 471.5M → 2023: 559.9M → 2024: 798.7M → 2025: 1,045.9M (2023→2025 CAGR 36.7%) | FY2022–25 | Filed | financials |
| F-119 | Balance-sheet turnaround | Total equity +998.6M end-2025 (owners +983.9M) vs attributable −1,460.4M end-2024 — pre-IPO preferred-share liabilities cleared at listing | 2025-12-31 | Filed | financials |
| F-120 | H1 2025 results | Revenue 449.5M (+25.6%); GM 37.6%; adjusted NP 38.8M (+126.1%), margin 8.6%; combined revenue incl. managed 522.5M | H1 2025 | Filed | financials |
| F-124 | Gross margin by segment 2022/23/24 | Total 29.9/36.5/33.9%; centers 28.7/34.1/31.8%; food 43.7/63.3/61.5% | 2024 | Filed | financials |
| F-126 | Operating cash flow | Positive every year: +24.1 / +56.7 / +49.1M (2022/23/24) — cash-generative even through the statutory-loss years | 2024 | Filed | financials |
| F-228 | Market position (F&S) | Largest postpartum care+recovery group in Asia AND China by 2024 center revenue (RMB 628M, 1.2% share; No.2 = 418M); fastest-growing scaled group (26.4% CAGR); No.1 ultra-premium (374M vs 89M) | 2024 | Filed | market |
| F-229 | Market context (FY2025 results) | China home care industry RMB 805.3B (2025E) → >928.0B (2026E); postpartum+childcare+nutrition 298.4B in 2025 (+17.5%) | FY2025 | Filed | market |
| F-230 | Market size (F&S) | Postpartum care+recovery: RMB 38.6B (2019) → 67.5B (2024), CAGR 11.8%; → 79.3B (2025E) → 200.8B (2030E), CAGR 20.4% | 2025-06-18 | Filed | market |
| F-231 | Penetration & headroom (F&S) | Postpartum care services 7.5% (2019) → 17.0% (2024); centers 1.3% → 6.0%; South Korea / Taiwan >60% | 2025-06-18 | Filed | market |
| F-232 | Adjacent markets (F&S) | Family care industry 711.3B (2024) → 1,443.8B (2030E); home childcare 35.8B → 105.2B (2030E); China births 14.7M (2019) → 9.5M (2024) | 2025-06-18 | Filed | market |
| F-233 | Competitive ranking (F&S) | No.1 by 2024 center revenue: Group 628M (1.2%) vs A 418M (0.8%), E-Korea 403M, B 366M, F 279M | 2024-12-31 | Filed | market |
| F-401 | Natal-policy tailwind | National childcare subsidy RMB 3,600/child/yr for under-3s (from 2025-01-01; >24M recipients); under-3 tax deduction raised to RMB 2,000/mo | 2025 | Analyst | market |
| F-174 | Mainland center count | 140 mainland centers as of 2025-12-31 (net +63 from 77) | 2025-12-31 | Filed | network |
| F-175 | Global network scale | 140 stores across 41 cities worldwide; No.1 in postpartum care in Asia by scale; outlook 'nearly 150 stores' | 2026-03-30 | Filed | network |
| F-180 | Center network by year | 2022: 36 → 2023: 43 → 2024: 77 → Jun 2025: 96 (62 self-op / 34 managed) | 2025-06-10 | Filed | network |
| F-181 | Footprint at prospectus | 27 mainland cities + HK + Singapore + Greater LA; ~30 cities, 3 countries | 2025-06-10 | Filed | network |
| F-185 | Footprint + 2026 plan | 140 stores / 41 cities at AR date; 2026 plan: 15 new stores in 10 cities; countries: China (incl. HK), Singapore, US, Thailand | 2026-04-29 | Filed | network |
| F-294 | Overseas footprint FY2025 | 4 overseas cities, 8 overseas centers in 2025; overseas GMV +280.0% YoY (off a ~2.3%-of-revenue base); markets: Singapore, North America, Australia | FY2025 | Filed | network |
| F-295 | FY2026 outlook | Organic + M&A; 'only postpartum brand globally with total scale >RMB 1B'; overseas into Europe + Middle East; Dr. Bella across nearly 150 stores; no quantitative guidance | 2026-03-30 | Filed | network |
| F-296 | Five-city expansion (signed) | Eastern US, UK, France, Thailand, Australia; strategic agreements SIGNED with partners in NY, London, Paris, Bangkok | 2026-02-11 | Filed | network |
| F-297 | Wuhan Freya acquisition | 30–40% minority stakes in 4 Wuhan Freya (弗蕾亚) companies for ~RMB 22.4M; board control of 3 (consolidated); option to 60–80%. Freya: est. 2013, 3 shops, 160+ rooms, ASP ~RMB 50k, ~10,000 HNW families | 2026-06-22 | Filed | network |
| F-298 | US debut | Jul 15 2025: Waldorf Astoria Monarch Beach (CA) + Baccarat Hotel New York | 2025-07-15 | Press | network |
| F-014 | Company rename | SAINT BELLA Inc. → SAINT BELLA GROUP LIMITED (聖貝拉集團有限公司); EGM 2026-02-05 | 2026-03 | Filed | ownership |
| F-015 | Share buyback | Up to HK$100M on-market buyback, price cap HK$6.85, 2026-06-30 → 2028-06-29; rationale: price below intrinsic value | 2026-06-30 | Filed | ownership |
| F-016 | Insider buying & lock-up | Controlling shareholder increased his stake with a voluntary lock-up (2026-01-09); 2025 incentive plan authorises repurchase up to 2% of shares via Futu Trust | 2026-01-09 | Filed | ownership |
| F-017 | Listing | Dealings commenced 2025-06-26, HKEX Main Board, stock code 2508 | 2025-06-26 | Filed | ownership |
| F-018 | Global offering | 95,420,000 offer shares at HK$6.58 fixed price; board lot 500 | 2025-06-18 | Filed | ownership |
| F-019 | Final offer outcome | Offer Size Adjustment Option fully exercised: 109,733,000 shares at HK$6.58; net proceeds HK$629.95M; HK tranche 193.00x, intl 15.59x subscribed | 2025-06-25 | Filed | ownership |
| F-020 | Market cap at offer price | HK$3,917.9M | 2025-06-18 | Filed | ownership |
| F-023 | Use of proceeds | ~29% network expansion; ~37% new services/products (incl. elderly care, retail, recovery); ~6% training; ~18% R&D/AI/data; ~9% working capital | 2025-06-18 | Filed | ownership |
| F-117 | IPO proceeds deployment | Net HK$709.1M raised (incl. over-allotment); only HK$113.1M (~16%) deployed in 2025 — dry powder for expansion + M&A | 2025-12-31 | Filed | ownership |
| F-129 | Share price vs IPO | IPO HK$6.58 (Jun 2025); ~HK$5.45 (Feb 2026); ~HK$3.39 (Jul 2026) ≈ −48% vs IPO; award trustee bought at avg HK$3.81 | 2026-07-10 | Press | ownership |
| F-373 | Ownership & strategic holders | Danny Xiang + vehicles ~35.7% controlling; strategic holders incl. Tencent, Swire Properties, SHK Strategic, Mirae Asset | 2025-06-18 | Filed | ownership |
| F-374 | L Catterton cooperation | Strategic cooperation announced via HKEX voluntary announcement (2026-03-18): technology & consumer-insight support, joint investment incubation + acquisitions toward a multi-brand global home-care group | 2026-03-18 | Filed | ownership |
| F-375 | Founder | Danny Xiang (向华), 38 — founder / Chairman / CEO; Oxford engineering; ex-UBS Asia M&A | 2025-06-18 | Filed | ownership |
| F-376 | Co-founder | Minee Lin (林宛颐), 37 — co-founder & COO since Jul 2017 | 2025-06-18 | Filed | ownership |
| F-377 | Substantial shareholders post-IPO | Danny Xiang 35.68%; Minee Lin 9.98%; Tencent Mobility 9.75% | 2025-06-18 | Filed | ownership |
| F-378 | Pre-IPO investor register | Tencent 11.61% (RMB 150M Series C), Gaorong 8.26%, Ningbo Tangzhu 6.61%, SHK 2.98%, China Life 1.96%, Mirae 1.75%, C Capital (Adrian Cheng) 1.69%, Swire 0.68%; total pre-IPO raised >RMB 300M | 2025-06-18 | Filed | ownership |
| F-379 | Cornerstone investors | US$41.46M / 49.443M shares (51.82% of base): GIMM $6.37M, ChinaAMC(HK) $4.0M, JKKB $13.08M, Carl Wu $1.0M, SS Morgan $6.0M, Minwise $4.0M, Wang Qianqing $7.0M | 2025-06-18 | Filed | ownership |
| F-381 | Board & INEDs | Liang Jun (Tencent, non-exec); INEDs Wu Shuqing, Rainer Bürkle (ex-Marriott Greater China luxury VP), Shen Guanxian (ex-GS/Citi/CICC) | 2026-07-22 | Press | ownership |
| F-382 | L Catterton scope | L Catterton (~$40B AUM, 300+ brands): international expansion, HNW consumer insights, membership-system optimization, M&A pipeline | 2026-05-14 | Press | ownership |
| F-022 | Top prospectus risk factors | Competition; growth-execution; service quality; negative publicity; marketing efficiency; dependence on hotel relationships (generally no long-term agreements); new/acquired centers underperforming; incidents/liability; regulatory compliance | 2025-06-18 | Filed | risks |
| F-056 | Flagship pricing power (chairman) | Saint Bella brand ASP RMB 267,000, +11.6%; double-digit ASP growth 8 consecutive years; never cut prices | FY2025 | Filed | unit-econ |
| F-057 | Center revenue by brand 2024 | Saint Bella care 269.6M + recovery 54.8M; Baby Bella care 222.4M + recovery 32.4M; Bella Isla 43.9M + 5.4M | 2024 | Filed | unit-econ |
| F-176 | ASP by brand FY2025 | Group RMB 156,059 (+5.0%); Saint Bella 266,796 (+11.6%); Baby Bella 108,375 (+12.6%); Bella Isla 171,896 (+2.8%) | FY2025 | Filed | unit-econ |
| F-177 | Secondary-sales conversion & diversified mix | 95.5% comprehensive secondary-sales conversion; diversified offerings 29.5% of revenue | FY2025 | Filed | unit-econ |
| F-179 | Home care metrics | ~9,500 licensed baby-sitters (+36.0%); avg contract 122.8 days; 823 customers (+20.9%); renewal ~56.7% | FY2025 | Filed | unit-econ |
| F-182 | Pricing 2024 (prospectus) | Avg revenue/customer: Saint Bella 239,155; Bella Isla 167,197; Baby Bella 96,246; per room-night RMB 7,015; 28-day packages from 138,800 / 108,800 / 68,800 | 2024 | Filed | unit-econ |
| F-183 | Hotel asset-light model | Centers inside upscale hotels; 405/459/867 rooms reserved 2022/23/24; new centers cash-flow positive within ~3 months; minimal renovation capex | 2024 | Filed | unit-econ |
| F-184 | Staffing & volumes (prospectus) | 693 qualified nursing specialists; 4,439 postpartum packages sold 2024 (~38% via referrals/own channels) | 2024 | Filed | unit-econ |